50932 Federal Register / Vol. 71, No. 166 / Monday, August 28, 2006 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Diabetic 

Neuropathy. 

Date: August 29, 2006. 

Time: 5:30 p.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: William C. Benzing, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5206, 

MSC 7846, Bethesda, MD 20892, (301) 435–

1254, benzingw@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Confocal 

Microscopy Shared Instrumentation Panel. 

Date: September 18–19, 2006. 

Time: 8:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Beacon Hotel and Corporate 

Quarters, 1615 Rhode Island Avenue, NW., 

Washington, DC 20036. 

Contact Person: Laura M. Roman, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2138, 

MSC 7720, Bethesda, MD 20892, 301–435–

0715, romanl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Bacterial 

Pathogenesis. 

Date: September 20, 2006. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692, (301) 

435–1149, elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Program 

Project Review: Cryo-Electon Microscopy. 

Date: September 25, 2006. 

Time: 1 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Sally Ann Amero, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4190, 

MSC 7849, Bethesda, MD 20892, 301–435–

1159, ameros@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–83.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: August 21, 2006. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 06–7175 Filed 8–25–06; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Prospective Grant of Exclusive 

License: System and Methods for 

Detecting and Characterizing 

Macromolecular Interactions in 

Solution 

AGENCY: National Institutes of Health, 

Public Health Service, HHS. 

ACTION: Notice. 

SUMMARY: This is notice, in accordance 

with 35 U.S.C. 209(c)(1) and 37 CFR 

404.7(a)(1)(i), that the National 

Institutes of Health (NIH), Department 

of Health and Human Services, is 

contemplating the grant of an exclusive 

license to practice the inventions 

embodied in PCT (application number 

pending) filed July 28, 2006 from U.S. 

provisional application 60/703,814 (E–

167–2005/0–US–01), entitled ‘‘System 

and Methods for Detecting and 

Characterizing Macromolecular 

Interactions in Solution’’ (Inventors: 

Drs. Allen Minton and Arun Attri) to 

Wyatt Technology Corporation 

(hereafter Wyatt), having a place of 

business in Goleta, California. The 

patent rights in these inventions have 

been assigned to the United States of 

America. 

DATES: Only written comments and/or 

application for a license, which are 

received by the NIH Office of 

Technology Transfer on or before 

October 27, 2006 will be considered. 

ADDRESSES: Requests for a copy of the 

patent application, inquiries, comments 

and other materials relating to the 

contemplated license should be directed 

to: Chekesha Clingman, Ph.D., Office of 

Technology Transfer, National Institutes 

of Health, 6011 Executive Boulevard, 

Suite 325, Rockville, MD 20852–3804; email: clingmac@mail.nih.gov; telephone: 

(301) 435–5018; facsimile: (301) 402–

0220. 

SUPPLEMENTARY INFORMATION: The 

present invention relates to systems and 

methods for sensitive detection and 

characterization of macromolecular 

interactions in homogenous or 

heterogeneous solutions of 

macromolecules, such as proteins, DNA, 

RNA, biopolymers, organic and 

inorganic polymers, macromolecular 

pharmaceutical compounds and others. 

The methods employed by this system 

do not require the need for labeling or 

chemical modification of any test 

substance, and it is more rapid than any 

conventional methods. The system 

includes a dispenser to dispense a 

solution containing the macromolecule, 

and one or more detectors to measure a 

light scattering and concentration 

associated with the macromolecule in 

solution. For instance, the first detector 

can be a light scattering detector (such 

as a static light-scattering detector). The 

second detector (such as a UV–Vis 

detector) can be added in to measure 

light absorbance and hence 

concentration. The detectors can be 

arranged in parallel, to receive identical 

flow of solution from the dispenser, so 

that at any given time point, both 

detectors collect data on flow of 

identical concentrations. 

The prospective exclusive license will 

be royalty bearing and will comply with 

the terms and conditions of 35 U.S.C. 

209 and 37 CFR 404.7. The prospective 

exclusive license may be granted unless, 

within 60 days from the date of this 

published Notice, NIH receives written 

evidence and argument that establishes 

that the grant of the license would not 

be consistent with the requirements of 

35 U.S.C. 209 and 37 CFR 404.7. 

The field of use may be limited to the 

development of a system and method 

for detecting and characterizing 

macromolecular interactions in 

solution. 

Properly filed competing applications 

for a license filed in response to this 

notice will be treated as objections to 

the contemplated license. Comments 

mstockstill on PROD1PC61 with NOTICES